Аннотация:
Although phosphodiesterase type 5 inhibitors are the first-line treatment of ED, some patients remain unresponsive to any pharmacotherapy. To date, the use of stem cells is considered as a new treatment modality for erectile dysfunction. The validity of this assumption has been experimentally proved in preclinical and clinical studies. The main focus is on the stem cells derived from adipose tissue, due to advantages over other sources.
Chaliy M.E.
Glybochko P.V.
Epifanova M.V.
Krasnov A.O.
Department of Urology of Sechenov First Moscow State Medical University.
Research Institute of Uronephrology and Human Reproductive Health of Sechenov First Moscow State Medical University.
Prospects for application of stem cells from adipose tissue in treating erectile dysfunction
Текст визуальный электронный
Urologiia (Moscow, Russia : 1999)
№ 6 С. 98-103
2015
cell therapy
erectile dysfunction
regenerative medicine
stem cells
stromal-vascular fraction
Статья
Adipose Tissue A10.165.114
Adipose Tissue cytology A10.165.114
Жировая ткань A10.165.114
Жировая ткань цитология A10.165.114
Erectile Dysfunction C12.100.500.214 C12.100.875.486 C12.200.294.214 F03.835.400
Erectile Dysfunction therapy C12.100.500.214 C12.100.875.486 C12.200.294.214 F03.835.400
Эректильная дисфункция C12.100.500.214 C12.100.875.486 C12.200.294.214 F03.835.400
Эректильная дисфункция терапия C12.100.500.214 C12.100.875.486 C12.200.294.214 F03.835.400
Humans B01.050.150.900.649.313.988.400.112.400.400
Человек B01.050.150.900.649.313.988.400.112.400.400
Male
Мужской
Stem Cell Transplantation E02.095.147.500.500 E04.936.225.687
Стволовых клеток трансплантация E02.095.147.500.500 E04.936.225.687
Stem Cells A11.872
Стволовые клетки A11.872
Journal Article V02.600
Журнальная статья V02.600
Although phosphodiesterase type 5 inhibitors are the first-line treatment of ED, some patients remain unresponsive to any pharmacotherapy. To date, the use of stem cells is considered as a new treatment modality for erectile dysfunction. The validity of this assumption has been experimentally proved in preclinical and clinical studies. The main focus is on the stem cells derived from adipose tissue, due to advantages over other sources.